Interchange Capital Partners’s Exact Sciences EXAS Stock Holding History

Interchange Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,110	Closed	-$268K	–	155
2023 Q2	$268K	Sell	3,110 -850	-21%	-$66.3K	0.2%	118
2023 Q1	$268K	Sell	3,960 -816	-17%	-$52.5K	0.15%	158
2022 Q4	$236K	Sell	4,776 -4,246	-47%	-$173K	0.24%	107
2022 Q3	$293K	Sell	9,022 -647	-7%	-$26.7K	0.32%	87
2022 Q2	$380K	Sell	9,669 -427	-4%	-$22.8K	0.43%	68
2022 Q1	$705K	Buy	10,096 +3,413	+51%	+$249K	0.72%	33
2021 Q4	$520K	Buy	+6,683	New	+$590K	0.52%	57
2021 Q2	–	Sell	-5,205	Closed	-$752K	–	135
2021 Q1	$752K	Buy	5,205 +344	+7%	+$47.1K	0.41%	80
2020 Q4	$644K	Buy	+4,861	New	+$588K	0.35%	78

Other funds holding EXAS

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Interchange Capital Partners's EXAS Position: Q3 2023 in Review

Interchange Capital Partners sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 3,110 shares — an estimated $268K sold.

Interchange Capital Partners first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $752K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

Interchange Capital Partners reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
Interchange Capital Partners sold 3,110 Exact Sciences shares in Q3 2023, an estimated $268K.
Interchange Capital Partners first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
Interchange Capital Partners's Exact Sciences position peaked at $752K in Q1 2021.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Interchange Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.